Biotech Showcase 2024

Expertise for Every Modality in Early Development

Certara offers new and emerging biotechs a modern and data driven approach to drug development. Starting with the end in mind, Certara’s cross functional experts will support your team to further your scientific insights, optimize resources, and de-risk your therapy development journey.

Expertise for every modality:

• Small molecules, Biologics (monoclonal antibodies, ADCs)
• Complex biologics (Bispecific Abs, siRNA, oligonucleotides)
• Cell and Gene Therapies, Vaccines, Drug-device combos and Devices

Delivering comprehensive support for programs in late discovery and first-in-human studies (FIH).

• Target product profile development & product development strategy
• FIH enabling activity planning & stewardship
• FIH execution & reporting
• Pre-IND strategy, briefing document support. IND writing & submission

Additional Resources

• “Where do I start?”: Strategies for selecting the first dose for human clinical trials
• How the Simcyp Discovery Simulator will Accelerate Early Drug Development
• Our Factsheet